Restricting post-surgery blood transfusion is safe for some hip patients

Hip problems have been one of the major concerns worldwide, especially after the release of data that complications have caused DePuy hip replacements to fail at a much higher rate than other hip replacement models. Newly-released information presented that about 12 to 13 percent of patients who received one of the recalled hip implants needed a replacement surgery after just five years. DePuy is a subsidiary company of Johnson and Johnson, which issued a worldwide recall of their products. Moreover, from 2008 until the recall of the products, the Food and Drug Administartion (FDA) have been receiving several complaints from patients, whom needed to undergo another hip replacement surgery. Several DePuy lawsuit have also been filed by the victimized patients. See http://www.depuyhipreplacementlawsuit.com for more information.

Restricting post-surgery blood transfusion is safe for some hip patients. See http://www.depuypinnaclelawsuit.com/